Clinical Trial Update: Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at Tehran University of Medical Sciences is evaluating allogeneic adipose-derived stem cells in infants with spinal muscular atrophy;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Allogeneic adipose-derived stem cells

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman] | Phase 1, Phase 2 | Status: UNKNOWN